Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.4901606228879094e-73,77.95901985635825,13032.905525259148,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",8.566152542734408e-71,0,0,69
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,3.813413620791888e-46,30.152156166814553,3153.3242369821105,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'SLC25A5', 'SLC25A6', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",6.559071427762048e-44,0,0,53
3,Oxidative phosphorylation WP623,4.010878189352984e-29,32.71568752389448,2139.1465533547876,"['NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'ATP5PO']",4.599140323791422e-27,0,0,32
4,Nonalcoholic fatty liver disease WP4396,3.315283350671113e-24,9.487971487971487,512.9529383476192,"['NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFAB1', 'CYCS', 'BAX']",2.8511436815771574e-22,0,0,44
5,Mitochondrial complex I assembly model OXPHOS system WP4324,3.6127271566566707e-17,16.36065646484808,619.4060059129421,"['NDUFA8', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFA3', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAB1']",2.485556283779789e-15,0,0,23
6,Mitochondrial CIV Assembly WP4922,4.65592866008163e-13,19.05938242280285,541.2000230920767,"['COA3', 'COX7B', 'PET100', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'COX14']",2.6693990984468014e-11,0,0,16
7,Cellular Proteostasis WP4918,1.9047414622044185e-06,94.15592028135991,1240.1430933929948,"['VBP1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",9.360443757118857e-05,0,0,5
8,Pyrimidine metabolism WP4022,2.9726811784429885e-06,4.606060606060606,58.61694034311314,"['NME2', 'NME1', 'POLE4', 'POLD4', 'ZNRD1', 'POLD2', 'POLE3', 'POLR2E', 'POLR2G', 'POLR2I', 'POLE', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'POLR2L']",0.00012782529067304851,0,0,16
9,Base Excision Repair WP4752,1.1582019536436674e-05,8.098435133770822,92.04727293089714,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'NTHL1', 'APEX1', 'POLD2', 'POLE3', 'POLE']",0.00044269052450380175,0,0,9
10,Mitochondrial complex III assembly WP4921,5.6301601308947975e-05,12.562597809076681,122.9223510247212,"['UQCRB', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.0019367750850278103,0,0,6
11,DNA Mismatch Repair WP531,0.00010079130834923321,8.250293772032903,75.92298549501706,"['POLE4', 'POLD4', 'RFC3', 'POLD2', 'POLE3', 'RPA2', 'POLE']",0.0031520190974669293,0,0,7
12,Nucleotide Excision Repair WP4753,0.0003030520651812783,4.8548207975769815,39.331844986695224,"['POLE4', 'POLD4', 'RFC3', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'POLE', 'GTF2H5']",0.008687492535196644,0,0,9
13,Proteasome Degradation WP183,0.0006974085331055874,3.8542067770504427,28.012911315707242,"['PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'PSMB5', 'H2AFZ', 'PSMA2', 'PSME3', 'PSME1', 'PSMA7']",0.01845450272217862,0,0,10
14,Computational Model of Aerobic Glycolysis WP4629,0.001625959258675207,10.74406155904985,68.99468160378652,"['TPI1', 'PGK1', 'ALDOA', 'PFKM']",0.039952141784590806,0,0,4
15,DNA Repair Pathways Full Network WP4946,0.0028022199350546586,2.5211690363349133,14.817776049708375,"['FEN1', 'RFC3', 'CENPX', 'RPA2', 'RAD23A', 'GTF2H5', 'POLE4', 'POLD4', 'NEIL2', 'NTHL1', 'APEX1', 'POLD2', 'POLE3', 'POLE']",0.06426424384392017,0,0,14
16,7q11.23 copy number variation syndrome WP4932,0.0036143812533059377,2.666499791405924,14.993287285163069,"['ATP5F1A', 'ATP5F1B', 'DNAJC30', 'ATP5PB', 'CFL1', 'ATP5MC2', 'EIF4H', 'ATP5PO', 'ATP5MC3', 'VAMP2', 'ATP5F1E', 'ATP5MC1']",0.07770919694607765,0,0,12
17,Translation Factors WP107,0.0038753767971581236,3.5066484268125855,19.472812801507406,"['EEF1B2', 'EIF2B2', 'EIF5', 'EIF6', 'EIF3I', 'EIF4H', 'EIF4B', 'EIF1']",0.07841938930719967,0,0,8
18,mRNA Processing WP411,0.00471964010903408,2.362559241706161,12.653921000442114,"['SF3B5', 'SF3A1', 'NCBP2', 'SNU13', 'LSM2', 'LSM7', 'SNRPD1', 'SNRPG', 'SNRPE', 'SNRPB2', 'DNAJC8', 'HNRNPA1', 'SNRPB', 'SRSF9']",0.08680192719060054,0,0,14
19,Eukaryotic Transcription Initiation WP405,0.004794292490178518,3.767097532314924,20.117540699097887,"['TAF13', 'POLR2E', 'POLR2G', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.08680192719060054,0,0,7
20,VEGFA-VEGFR2 Signaling Pathway WP3888,0.0076638693659446646,1.6478014659081215,8.026833584523954,"['YWHAE', 'RPL5', 'SET', 'NOTCH4', 'CCDC124', 'ARPC5L', 'CRIP2', 'TXN', 'RPL10A', 'RPL7', 'ACTG1', 'RPL18A', 'TMSB4X', 'CFL1', 'RACK1', 'AP2S1', 'PGK1', 'RPLP2', 'ELOC', 'ATP6V1E1', 'TMSB10', 'ACP1', 'HRAS', 'SDF2L1', 'SSR4', 'SARS', 'RPL13A', 'DNAJA1', 'CYCS', 'RPL27', 'RPL26', 'ALDOA']",0.13181855309424823,0,0,32
21,Selenium Micronutrient Network WP15,0.008613959397027448,2.7810345826333775,13.22207074246196,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'TXN', 'SEPHS2', 'SELENOH', 'SOD1', 'MSRB1']",0.1411048586941639,0,0,9
22,Glycolysis and Gluconeogenesis WP534,0.011485612494868664,3.528169014084507,15.759131811645828,"['TPI1', 'GOT1', 'MPC2', 'PGK1', 'ALDOA', 'PFKM']",0.1795932135561282,0,0,6
23,DNA Replication WP466,0.014664262518808138,3.3202154101077053,14.019084531366238,"['POLD4', 'RFC3', 'POLD2', 'RPA2', 'POLE', 'UBA52']",0.21932636115086956,0,0,6
24,Cori Cycle WP1946,0.025366222316247293,5.6329824561403505,20.69747484520966,"['TPI1', 'PGK1', 'ALDOA']",0.3635825198662112,0,0,3
25,Fatty acid transporters WP5061,0.03109352597193727,5.120574162679426,17.772261704171246,"['FABP3', 'FABP5', 'FABP6']",0.4278469173738568,0,0,3
26,Synaptic Vesicle Pathway WP2267,0.033408201981697375,2.686452045606975,9.131126498627221,"['RAB3A', 'AP2S1', 'PARK7', 'SYP', 'AP2M1', 'VAMP2']",0.42821988945863504,0,0,6
27,Peroxiredoxin 2 induced ovarian failure WP4873,0.033610282021462635,9.380841121495328,31.82847391079713,"['STAR', 'BAX']",0.42821988945863504,0,0,2
28,Photodynamic therapy-induced unfolded protein response WP3613,0.035508733115937205,3.578231292517007,11.944052357762546,"['NARS', 'XBP1', 'DDIT3', 'HSP90B1']",0.4292832932757516,0,0,4
29,TP53 network WP1742,0.037437496506606244,4.693567251461988,15.41875562354397,"['SUMO1', 'GADD45A', 'BAX']",0.4292832932757516,0,0,3
30,Cholesterol Biosynthesis Pathway WP197,0.037437496506606244,4.693567251461988,15.41875562354397,"['IDI1', 'NSDHL', 'PMVK']",0.4292832932757516,0,0,3
31,Ferroptosis WP4313,0.04160150798377368,2.8475256669863938,9.054046322948816,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'VDAC2']",0.46164254020703704,0,0,5
32,Dual hijack model of Vif in HIV infection WP3300,0.04549511724010227,7.504205607476636,23.189123000499194,"['ELOB', 'ELOC']",0.48907251033109944,0,0,2
33,Modulators of TCR signaling and T cell activation WP5072,0.05066488978157222,2.39991009889122,7.157784950001448,"['FIBP', 'NDUFB10', 'ELOB', 'IKBKG', 'RNF7', 'MEF2D']",0.5253914310952988,0,0,6
34,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.05192822284081443,4.022556390977444,11.898290763128966,"['EIF5', 'EIF3I', 'EIF1']",0.5253914310952988,0,0,3
35,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.0586590805747834,6.253115264797508,17.733915489603987,"['HSD11B2', 'STAR']",0.5582317481909099,0,0,2
36,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.0586590805747834,6.253115264797508,17.733915489603987,"['ELOB', 'ELOC']",0.5582317481909099,0,0,2
37,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.060042368264719974,3.754152046783626,10.559321587832729,"['RAB5C', 'RRAS', 'HRAS']",0.5582317481909099,0,0,3
38,Ciliary landscape WP4352,0.068527161747783,1.5544726595979137,4.16680296645914,"['NUDC', 'NDUFA5', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'PSMD8', 'PSMD7', 'EXOSC4', 'RAB14', 'NEFL', 'SNRPB2', 'COPS8', 'DCAF11', 'CALM2']",0.6203511484536146,0,0,16
39,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.07294222732235624,5.359479305740988,14.031586086134125,"['CHI3L1', 'BAX']",0.6433878512536038,0,0,2
40,Myometrial relaxation and contraction pathways WP289,0.0849572442378049,1.656,4.08304545366501,"['RGS4', 'YWHAE', 'GNG3', 'YWHAQ', 'PRKAR1A', 'YWHAB', 'CRH', 'CALM3', 'CALM2', 'ACTG1', 'YWHAH']",0.7306323004451222,0,0,11
41,Exercise-induced Circadian Regulation WP410,0.08820337770623748,2.2360855244794284,5.429461669161074,"['DNAJA1', 'IDI1', 'HSPA8', 'SUMO1', 'STBD1']",0.7400478519742852,0,0,5
42,Cytosolic DNA-sensing pathway WP4655,0.09457491350025651,2.183947217754028,5.150540362706876,"['POLR2E', 'IKBKG', 'POLR3K', 'POLR2K', 'POLR2L']",0.7746135772401962,0,0,5
43,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.1042898914934101,4.1679646936656285,9.422021125300011,"['IDI1', 'PMVK']",0.8343191319472808,0,0,2
44,Pathogenic Escherichia coli infection WP2272,0.11503811880442721,2.041133594984454,4.413934534650138,"['TUBA1A', 'YWHAQ', 'ARPC5L', 'ARPC5', 'ACTG1']",0.886315948656844,0,0,5
45,Canonical and non-canonical Notch signaling WP3845,0.11947316923781603,2.6805346700083543,5.695234061340382,"['RRAS', 'NOTCH4', 'DLL3']",0.886315948656844,0,0,3
46,Cell cycle WP179,0.11982805626583445,1.6268007610763795,3.45157899094255,"['YWHAE', 'CDKN2D', 'ANAPC13', 'YWHAQ', 'GADD45A', 'YWHAB', 'SKP1', 'ANAPC11', 'YWHAH']",0.886315948656844,0,0,9
47,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.12109549298509206,3.750934579439252,7.918882485593693,"['RRAS', 'IKBKG']",0.886315948656844,0,0,2
48,Prostaglandin Synthesis and Regulation WP98,0.12473784232892572,2.2082931533269043,4.596652750551705,"['HSD11B2', 'ANXA6', 'S100A6', 'PTGES']",0.8939545366906344,0,0,4
49,Androgen receptor signaling pathway WP138,0.13347919215653162,1.707830360004273,3.439245306139277,"['SUMO1', 'BAG1', 'RACK1', 'DSTN', 'PARK7', 'FKBP4', 'RAN']",0.937078410241773,0,0,7
50,Homologous recombination WP186,0.1385008259057617,3.4097281223449447,6.7406198872010625,"['POLD4', 'POLD2']",0.9528856822316405,0,0,2
51,Calcium Regulation in the Cardiac Cell WP536,0.14779296680558882,1.5036792452830188,2.8749487929739117,"['RGS4', 'YWHAE', 'GNG3', 'YWHAQ', 'PRKAR1A', 'YWHAB', 'ANXA6', 'CALM3', 'CALM2', 'YWHAH']",0.9968780506102461,0,0,10
52,Gastric Cancer Network 2 WP2363,0.1548909398552151,2.345029239766082,4.373559318389438,"['RFC3', 'S100A6', 'COL9A3']",0.9987231845424268,0,0,3
53,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.17470429863237608,2.8847951114306256,5.0329879555845265,"['CD63', 'SOD1']",0.9987231845424268,0,0,2
54,MED and Pseudoachondroplasia genes WP4789,0.1879177814382436,6.2469856087125635,10.443402842779236,['COL9A3'],0.9987231845424268,0,0,1
55,GABA receptor Signaling WP4159,0.19308226530609182,2.08408057179987,3.427560053694316,"['GABBR1', 'AP2S1', 'AP2M1']",0.9987231845424268,0,0,3
56,Alzheimer's disease WP2059,0.1952371779544511,1.5862924023011307,2.591272348320204,"['PSENEN', 'ATP5MD', 'CHP1', 'CYCS', 'CALM3', 'CALM2']",0.9987231845424268,0,0,6
57,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.20338975797418063,1.7867737258837961,2.8456714951747553,"['XBP1', 'MAP1LC3A', 'PPP1R11', 'DDIT3']",0.9987231845424268,0,0,4
58,Proximal tubule transport WP4917,0.20338975797418063,1.7867737258837961,2.8456714951747553,"['ATP6V1G1', 'ATP6V1E1', 'ATP6V1D', 'ATP6V1F']",0.9987231845424268,0,0,4
59,DNA damage response WP707,0.22353839897933436,1.5901007411528603,2.3822445223351085,"['GADD45A', 'SESN1', 'RPA2', 'CYCS', 'BAX']",0.9987231845424268,0,0,5
60,Melanoma WP4685,0.22353839897933436,1.5901007411528603,2.3822445223351085,"['GADD45A', 'BAX', 'CALM3', 'HRAS', 'CALM2']",0.9987231845424268,0,0,5
61,The alternative pathway of fetal androgen synthesis WP4524,0.22910264966931312,4.684947491248542,6.903668929973369,['STAR'],0.9987231845424268,0,0,1
62,Mitochondrial fatty acid synthesis pathway WP4317,0.22910264966931312,4.684947491248542,6.903668929973369,['MCAT'],0.9987231845424268,0,0,1
63,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.22910264966931312,4.684947491248542,6.903668929973369,['MAS1'],0.9987231845424268,0,0,1
64,Nanomaterial induced apoptosis WP2507,0.2311897798757279,2.3434579439252334,3.4320324693791613,"['BAX', 'CYCS']",0.9987231845424268,0,0,2
65,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.2329312208077924,1.5635013677217664,2.278040346501405,"['PSMD8', 'HSPA8', 'PSMC5', 'TUBA1A', 'PSMD7']",0.9987231845424268,0,0,5
66,Amyotrophic lateral sclerosis (ALS) WP2447,0.23328800678884906,1.8753216374269006,2.729495965007768,"['NEFL', 'BAX', 'SOD1']",0.9987231845424268,0,0,3
67,CAMKK2  Pathway WP4874,0.23328800678884906,1.8753216374269006,2.729495965007768,"['FIS1', 'MAP1LC3A', 'CALM2']",0.9987231845424268,0,0,3
68,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.23597528478937832,1.6673432214415822,2.407690639026074,"['RRAS', 'CHP1', 'IKBKG', 'CALM2']",0.9987231845424268,0,0,4
69,miRNA regulation of DNA damage response WP1530,0.24243350196648997,1.5377741048949705,2.1790686950534877,"['GADD45A', 'SESN1', 'RPA2', 'CYCS', 'BAX']",0.9987231845424268,0,0,5
70,p38 MAPK Signaling Pathway WP400,0.24701293577865596,1.8147142048670062,2.537541316956759,"['DDIT3', 'HRAS', 'MEF2D']",0.9987231845424268,0,0,3
71,Parkinson's disease pathway WP2371,0.24701293577865596,1.8147142048670062,2.537541316956759,"['SYT11', 'CYCS', 'PARK7']",0.9987231845424268,0,0,3
72,Imatinib and Chronic Myeloid Leukemia WP3640,0.25030515939290887,2.205470038482683,3.054740240066267,"['GADD45A', 'PIM2']",0.9987231845424268,0,0,2
73,Nucleotide metabolism WP404,0.25030515939290887,2.205470038482683,3.054740240066267,"['NME2', 'OAZ1']",0.9987231845424268,0,0,2
74,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.2608573833494104,1.7578947368421052,2.3622263295472603,"['STAR', 'CALM3', 'CALM2']",0.9987231845424268,0,0,3
75,miRNA Biogenesis WP2338,0.26820113107416504,3.7477246207701285,4.932073400512483,['RAN'],0.9987231845424268,0,0,1
76,Urea cycle and metabolism of amino groups WP497,0.26946068600227213,2.082814122533749,2.7312624268955075,"['ODC1', 'PYCR1']",0.9987231845424268,0,0,2
77,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.26946068600227213,2.082814122533749,2.7312624268955075,"['H3F3B', 'H2AFZ']",0.9987231845424268,0,0,2
78,Methionine De Novo and Salvage Pathway WP3580,0.26946068600227213,2.082814122533749,2.7312624268955075,"['ODC1', 'TXN']",0.9987231845424268,0,0,2
79,Genotoxicity pathway WP4286,0.26968107275523406,1.5628415300546448,2.0481276274978377,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1']",0.9987231845424268,0,0,4
80,Senescence and Autophagy in Cancer WP615,0.27902565775530724,1.389584420100852,1.77373717036929,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'MAP1LC3A', 'HRAS', 'GABARAP']",0.9987231845424268,0,0,6
81,G Protein Signaling Pathways WP35,0.27902565775530724,1.389584420100852,1.77373717036929,"['GNG10', 'GNG3', 'RRAS', 'PRKAR1A', 'HRAS', 'CALM2']",0.9987231845424268,0,0,6
82,TNF-alpha signaling pathway WP231,0.28784950740849513,1.372552387495706,1.7092634791840748,"['CDC37', 'BAX', 'IKBKG', 'TXN', 'HRAS', 'SKP1']",0.9987231845424268,0,0,6
83,G13 Signaling Pathway WP524,0.28881017076669513,1.654282765737874,2.054595464769401,"['ARHGDIB', 'CFL1', 'CALM2']",0.9987231845424268,0,0,3
84,Fas ligand pathway and stress induction of heat shock proteins WP314,0.30287351209704166,1.6069172932330826,1.9193663117434505,"['ARHGDIB', 'CYCS', 'ACTG1']",0.9987231845424268,0,0,3
85,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.30531880198440764,3.1229093737845197,3.7050159206464905,['NSDHL'],0.9987231845424268,0,0,1
86,Mevalonate pathway WP3963,0.30531880198440764,3.1229093737845197,3.7050159206464905,['PMVK'],0.9987231845424268,0,0,1
87,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.30531880198440764,3.1229093737845197,3.7050159206464905,['IKBKG'],0.9987231845424268,0,0,1
88,Unfolded protein response WP4925,0.30768485498834663,1.8742990654205607,2.2091973565834535,"['XBP1', 'DDIT3']",0.9987231845424268,0,0,2
89,Urea cycle and associated pathways WP4595,0.30768485498834663,1.8742990654205607,2.2091973565834535,"['GOT1', 'PYCR1']",0.9987231845424268,0,0,2
90,IL-18 signaling pathway WP4754,0.3136501134887833,1.1901688555347092,1.3799736552452255,"['NRN1', 'COX17', 'NDUFC1', 'BPGM', 'ARL4D', 'NACA', 'TMSB4X', 'STMN1', 'CYCS', 'BAX', 'RAE1', 'AARS', 'ITM2C']",0.9987231845424268,0,0,13
91,Small cell lung cancer WP4658,0.31464669336390133,1.323860811930406,1.5307867146261347,"['GADD45A', 'CYCS', 'BAX', 'IKBKG', 'CKS1B', 'SKP1']",0.9987231845424268,0,0,6
92,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.32346217152448153,1.2505098039215685,1.41141678558599,"['YWHAE', 'YWHAQ', 'PRKAR1A', 'YWHAB', 'ALDOA', 'VAMP2', 'HSP90B1', 'YWHAH']",0.9987231845424268,0,0,8
93,Notch Signaling Pathway Netpath WP61,0.32739557401048147,1.4149617780919976,1.5799266997691515,"['PSENEN', 'NOTCH4', 'SKP1', 'DLL3']",0.9987231845424268,0,0,4
94,NO/cGMP/PKG mediated Neuroprotection WP4008,0.33106883201859977,1.5198672356567093,1.6801052781777195,"['NEFL', 'CYCS', 'CALM2']",0.9987231845424268,0,0,3
95,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.33905894616448823,1.3886720444097493,1.501961720935409,"['TMSB4X', 'NEFL', 'PFN2', 'SOD1']",0.9987231845424268,0,0,4
96,Canonical NF-KB pathway WP4562,0.34055590273157865,2.676612768794799,2.883183005080652,['IKBKG'],0.9987231845424268,0,0,1
97,HIF1A and PPARG regulation of glycolysis WP2456,0.34055590273157865,2.676612768794799,2.883183005080652,['TPI1'],0.9987231845424268,0,0,1
98,Mitochondrial CII Assembly WP4920,0.34055590273157865,2.676612768794799,2.883183005080652,['SDHAF1'],0.9987231845424268,0,0,1
99,Metabolic reprogramming in colon cancer WP4290,0.34516165665564585,1.4797783933518005,1.574103022096828,"['PGK1', 'PYCR1', 'PYCR2']",0.9987231845424268,0,0,3
100,p53 transcriptional gene network WP4963,0.362414859491439,1.3389093342254934,1.3589470531863999,"['SIVA1', 'GADD45A', 'SESN1', 'BAX']",0.9987231845424268,0,0,4
101,Glycosylation and related congenital defects WP4521,0.36415673174825514,1.6295205201137748,1.6460942466989141,"['DPM2', 'DPM3']",0.9987231845424268,0,0,2
102,IL-3 signaling pathway WP286,0.37324716351609416,1.4056140350877193,1.385252931474778,"['YWHAQ', 'YWHAB', 'HRAS']",0.9987231845424268,0,0,3
103,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.37400760671990646,2.3418903150525088,2.3032002799334563,['DLL3'],0.9987231845424268,0,0,1
104,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.37400760671990646,2.3418903150525088,2.3032002799334563,['MEF2D'],0.9987231845424268,0,0,1
105,Supression of HMGB1 mediated inflammation by THBD WP4479,0.37400760671990646,2.3418903150525088,2.3032002799334563,['IKBKG'],0.9987231845424268,0,0,1
106,Cell Differentiation - Index WP2029,0.37400760671990646,2.3418903150525088,2.3032002799334563,['MEF2D'],0.9987231845424268,0,0,1
107,NLR Proteins WP288,0.37400760671990646,2.3418903150525088,2.3032002799334563,['IKBKG'],0.9987231845424268,0,0,1
108,Role of Osx and miRNAs in tooth development WP3971,0.37400760671990646,2.3418903150525088,2.3032002799334563,['NOTCH4'],0.9987231845424268,0,0,1
109,G1 to S cell cycle control WP45,0.37408612424571863,1.3153375241382144,1.2933309136890139,"['CDKN2D', 'GADD45A', 'RPA2', 'POLE']",0.9987231845424268,0,0,4
110,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.38720660330915296,1.371245186136072,1.3010331402303124,"['IDI1', 'NSDHL', 'PMVK']",0.9987231845424268,0,0,3
111,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.38720660330915296,1.371245186136072,1.3010331402303124,"['CFL1', 'BANF1', 'HRAS']",0.9987231845424268,0,0,3
112,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.39736484681457784,1.270591037192871,1.172628990078921,"['STMN1', 'BAX', 'IKBKG', 'HRAS']",0.9987231845424268,0,0,4
113,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.4008256299893928,1.4989719626168225,1.3704033148981185,"['RAB3A', 'NEFL']",0.9987231845424268,0,0,2
114,Oxidative Stress WP408,0.4008256299893928,1.4989719626168225,1.3704033148981185,"['TXN2', 'SOD1']",0.9987231845424268,0,0,2
115,Retinoblastoma gene in cancer WP2446,0.40275175270978186,1.2170186203011526,1.1067992134330444,"['RFC3', 'H2AFZ', 'STMN1', 'RPA2', 'POLE']",0.9987231845424268,0,0,5
116,ACE Inhibitor Pathway WP554,0.40576427607863697,2.0815506288085053,1.8775230493266912,['MAS1'],0.9987231845424268,0,0,1
117,TCA cycle in senescence WP5050,0.40576427607863697,2.0815506288085053,1.8775230493266912,['GOT1'],0.9987231845424268,0,0,1
118,Trans-sulfuration pathway WP2333,0.40576427607863697,2.0815506288085053,1.8775230493266912,['GOT1'],0.9987231845424268,0,0,1
119,Cytokines and Inflammatory Response WP530,0.40576427607863697,2.0815506288085053,1.8775230493266912,['HLA-DRB1'],0.9987231845424268,0,0,1
120,Dopamine metabolism WP2436,0.40576427607863697,2.0815506288085053,1.8775230493266912,['SOD1'],0.9987231845424268,0,0,1
121,Aryl Hydrocarbon Receptor Pathway WP2873,0.41878517858888015,1.4412293314162472,1.2544419613645943,"['CDC37', 'BAX']",0.9987231845424268,0,0,2
122,Endothelin Pathways WP2197,0.41878517858888015,1.4412293314162472,1.2544419613645943,"['RIIAD1', 'CALM2']",0.9987231845424268,0,0,2
123,Alanine and aspartate metabolism WP106,0.4359117047692663,1.8732788798133022,1.5554126173740757,['GOT1'],0.9987231845424268,0,0,1
124,Sulfation Biotransformation Reaction WP692,0.4359117047692663,1.8732788798133022,1.5554126173740757,['SULT4A1'],0.9987231845424268,0,0,1
125,Biomarkers for urea cycle disorders WP4583,0.4359117047692663,1.8732788798133022,1.5554126173740757,['GOT1'],0.9987231845424268,0,0,1
126,Transcriptional cascade regulating adipogenesis WP4211,0.4359117047692663,1.8732788798133022,1.5554126173740757,['DDIT3'],0.9987231845424268,0,0,1
127,Glycolysis in senescence WP5049,0.4359117047692663,1.8732788798133022,1.5554126173740757,['PGK1'],0.9987231845424268,0,0,1
128,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.4359117047692663,1.8732788798133022,1.5554126173740757,['HLA-DRB1'],0.9987231845424268,0,0,1
129,Purine metabolism WP4792,0.4359117047692663,1.8732788798133022,1.5554126173740757,['APRT'],0.9987231845424268,0,0,1
130,Sleep regulation WP3591,0.45385076220146175,1.3381174899866488,1.0570952243211476,"['STAR', 'CRH']",0.9987231845424268,0,0,2
131,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.45385076220146175,1.3381174899866488,1.0570952243211476,"['NDUFA13', 'IKBKG']",0.9987231845424268,0,0,2
132,16p11.2 proximal deletion syndrome WP4949,0.4547634722938032,1.17096018735363,0.9226906748336566,"['ALDOA', 'SEZ6L2', 'CDIPT', 'CCT4']",0.9987231845424268,0,0,4
133,Copper homeostasis WP3286,0.4555917162217769,1.2218154080854309,0.9605402382454602,"['COX17', 'ATOX1', 'SOD1']",0.9987231845424268,0,0,3
134,Serotonin and anxiety-related events WP3944,0.4645313491521416,1.7028747215445,1.3056387203574487,['CRH'],0.9987231845424268,0,0,1
135,Cancer immunotherapy by CTLA4 blockade WP4582,0.4645313491521416,1.7028747215445,1.3056387203574487,['HLA-DRB1'],0.9987231845424268,0,0,1
136,Genes targeted by miRNAs in adipocytes WP1992,0.4645313491521416,1.7028747215445,1.3056387203574487,['TMSB4X'],0.9987231845424268,0,0,1
137,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.4645313491521416,1.7028747215445,1.3056387203574487,['GABBR1'],0.9987231845424268,0,0,1
138,Iron metabolism in placenta WP2007,0.4645313491521416,1.7028747215445,1.3056387203574487,['FTH1'],0.9987231845424268,0,0,1
139,Osteoclast Signaling WP12,0.4645313491521416,1.7028747215445,1.3056387203574487,['ATP6V1G1'],0.9987231845424268,0,0,1
140,RalA downstream regulated genes WP2290,0.4645313491521416,1.7028747215445,1.3056387203574487,['HRAS'],0.9987231845424268,0,0,1
141,Non-small cell lung cancer WP4255,0.4772323938622691,1.1353346107444469,0.8398657172952592,"['GADD45A', 'CYCS', 'BAX', 'HRAS']",0.9987231845424268,0,0,4
142,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.48205919156021065,1.1707602339181287,0.8542901248806039,"['BEX3', 'SERBP1', 'RNF7']",0.9987231845424268,0,0,3
143,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.48205919156021065,1.1707602339181287,0.8542901248806039,"['TKFC', 'PIN1', 'IKBKG']",0.9987231845424268,0,0,3
144,Glutathione metabolism WP100,0.4917005470604463,1.5608712563204978,1.1080397036155523,['GPX4'],0.9987231845424268,0,0,1
145,Hedgehog Signaling Pathway Netpath WP47,0.4917005470604463,1.5608712563204978,1.1080397036155523,['SAP18'],0.9987231845424268,0,0,1
146,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.4917005470604463,1.5608712563204978,1.1080397036155523,['ANAPC11'],0.9987231845424268,0,0,1
147,Complement system WP2806,0.49933596162428906,1.101804656288745,0.7651770447189895,"['FKBP2', 'RPS19', 'CD59', 'TXN']",0.9987231845424268,0,0,4
148,BDNF-TrkB Signaling WP3676,0.5040829915804809,1.2083961410913475,0.8277687075635702,"['HOMER1', 'HRAS']",0.9987231845424268,0,0,2
149,Type 2 papillary renal cell carcinoma WP4241,0.5040829915804809,1.2083961410913475,0.8277687075635702,"['ELOB', 'ELOC']",0.9987231845424268,0,0,2
150,MAPK Cascade WP422,0.5040829915804809,1.2083961410913475,0.8277687075635702,"['RRAS', 'HRAS']",0.9987231845424268,0,0,2
151,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.5040829915804809,1.2083961410913475,0.8277687075635702,"['PGK1', 'BAX']",0.9987231845424268,0,0,2
152,PPAR signaling pathway WP3942,0.507899412102378,1.1237894736842104,0.7613357435043859,"['FABP3', 'FABP5', 'FABP6']",0.9987231845424268,0,0,3
153,Airway smooth muscle cell contraction WP4962,0.5174927256618849,1.4407144780540346,0.949084796739701,['CALM2'],0.9987231845424268,0,0,1
154,Cell Differentiation - Index expanded WP2023,0.5174927256618849,1.4407144780540346,0.949084796739701,['MEF2D'],0.9987231845424268,0,0,1
155,Cysteine and methionine catabolism WP4504,0.5174927256618849,1.4407144780540346,0.949084796739701,['GOT1'],0.9987231845424268,0,0,1
156,Galanin receptor pathway WP4970,0.5174927256618849,1.4407144780540346,0.949084796739701,['VAMP2'],0.9987231845424268,0,0,1
157,EGF/EGFR signaling pathway WP437,0.5309099930670678,1.019095638255302,0.6452534240299023,"['NDUFA13', 'CFL1', 'STMN1', 'AP2S1', 'NEDD8', 'HRAS', 'MEF2D', 'AP2M1']",0.9987231845424268,0,0,8
158,ERK Pathway in Huntington's Disease WP3853,0.5419775991712152,1.3377229538256377,0.8193962546958669,['HRAS'],0.9987231845424268,0,0,1
159,Overview of nanoparticle effects WP3287,0.5419775991712152,1.3377229538256377,0.8193962546958669,['BAX'],0.9987231845424268,0,0,1
160,22q11.2 copy number variation syndrome WP4657,0.5497640811092732,1.0176359651358378,0.6088170351725165,"['RANBP1', 'CYP26B1', 'MRPL40', 'EMC10', 'RAN']",0.9987231845424268,0,0,5
161,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.5512214271078085,1.101566794942276,0.6561137674684987,"['MAP1LC3A', 'EIF2B2']",0.9987231845424268,0,0,2
162,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.5512214271078085,1.101566794942276,0.6561137674684987,"['STAR', 'HRAS']",0.9987231845424268,0,0,2
163,Serotonin and anxiety WP3947,0.5652213562513713,1.2484636328276935,0.7122957488689873,['CRH'],0.9987231845424268,0,0,1
164,Cancer immunotherapy by PD-1 blockade WP4585,0.5652213562513713,1.2484636328276935,0.7122957488689873,['HLA-DRB1'],0.9987231845424268,0,0,1
165,NOTCH1 regulation of endothelial cell calcification WP3413,0.5652213562513713,1.2484636328276935,0.7122957488689873,['DLL3'],0.9987231845424268,0,0,1
166,Oxidative Damage WP3941,0.5662163464914302,1.070026702269693,0.6086087564206984,"['GADD45A', 'CYCS']",0.9987231845424268,0,0,2
167,Ras signaling WP4223,0.567338017070393,0.9852631578947368,0.5584471606980665,"['GNG10', 'GNG3', 'RAB5C', 'RRAS', 'CALM3', 'IKBKG', 'CALM2', 'HRAS']",0.9987231845424268,0,0,8
168,ATM Signaling Pathway WP2516,0.5808464941500401,1.0402388369678088,0.5651292700998395,"['GADD45A', 'IKBKG']",0.9987231845424268,0,0,2
169,Glycogen Synthesis and Degradation WP500,0.5951102716995688,1.0120611265471078,0.525268387942029,"['CALM3', 'CALM2']",0.9987231845424268,0,0,2
170,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.6082337082810662,1.1014482805957855,0.5476357699178216,['CDC37'],0.9987231845424268,0,0,1
171,Apoptosis Modulation by HSP70 WP384,0.6082337082810662,1.1014482805957855,0.5476357699178216,['CYCS'],0.9987231845424268,0,0,1
172,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.6082337082810662,1.1014482805957855,0.5476357699178216,['IDH3B'],0.9987231845424268,0,0,1
173,Aryl Hydrocarbon Receptor Netpath WP2586,0.6090071791575407,0.9853664535169699,0.4886680781041982,"['CDC37', 'HRAS']",0.9987231845424268,0,0,2
174,Common Pathways Underlying Drug Addiction WP2636,0.6090071791575407,0.9853664535169699,0.4886680781041982,"['CALM2', 'ACTG1']",0.9987231845424268,0,0,2
175,Pathways in clear cell renal cell carcinoma WP4018,0.6125013836415807,0.9477366377138114,0.4645843642595038,"['TPI1', 'PGK1', 'ALDOA', 'PFKM']",0.9987231845424268,0,0,4
176,Endometrial cancer WP4155,0.6149860153002659,0.951828724353256,0.46273700810509005,"['GADD45A', 'BAX', 'HRAS']",0.9987231845424268,0,0,3
177,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.6225377081578485,0.9600407380781213,0.4550123418949626,"['YWHAQ', 'ACTG1']",0.9987231845424268,0,0,2
178,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.6281186114471147,1.0401918838324906,0.4837165399822715,['HRAS'],0.9987231845424268,0,0,1
179,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.6281186114471147,1.0401918838324906,0.4837165399822715,['IKBKG'],0.9987231845424268,0,0,1
180,Ebstein-Barr virus LMP1 signaling WP262,0.6281186114471147,1.0401918838324906,0.4837165399822715,['IKBKG'],0.9987231845424268,0,0,1
181,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.6281186114471147,1.0401918838324906,0.4837165399822715,['BAX'],0.9987231845424268,0,0,1
182,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.6281186114471147,1.0401918838324906,0.4837165399822715,['MAP1LC3A'],0.9987231845424268,0,0,1
183,Notch Signaling WP268,0.6357032425392063,0.935981308411215,0.4240214574309914,"['NOTCH4', 'DLL3']",0.9987231845424268,0,0,2
184,Hepatitis B infection WP4666,0.6359848924439645,0.9202262756869083,0.4164764403043419,"['YWHAQ', 'YWHAB', 'CYCS', 'BAX', 'IKBKG', 'HRAS']",0.9987231845424268,0,0,6
185,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.636534948317595,0.9205061834915157,0.4158073301946826,"['APEX1', 'HRAS', 'MYL12B']",0.9987231845424268,0,0,3
186,Adipogenesis WP236,0.6454893642520555,0.9083303930160825,0.3976184917973776,"['CYP26B1', 'GADD45A', 'DDIT3', 'CISD1', 'MEF2D']",0.9987231845424268,0,0,5
187,Vitamin D in inflammatory diseases WP4482,0.6469953277821637,0.985383528833753,0.4290519574457609,['IKBKG'],0.9987231845424268,0,0,1
188,Hippo-Yap signaling pathway WP4537,0.6469953277821637,0.985383528833753,0.4290519574457609,['YWHAQ'],0.9987231845424268,0,0,1
189,Purine metabolism and related disorders WP4224,0.6469953277821637,0.985383528833753,0.4290519574457609,['APRT'],0.9987231845424268,0,0,1
190,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6469953277821637,0.985383528833753,0.4290519574457609,['HRAS'],0.9987231845424268,0,0,1
191,Eicosanoid Synthesis WP167,0.6649149168662557,0.9360560093348892,0.38200089204141086,['PTGES'],0.9987231845424268,0,0,1
192,Glycerolipids and Glycerophospholipids WP4722,0.6649149168662557,0.9360560093348892,0.38200089204141086,['CDIPT'],0.9987231845424268,0,0,1
193,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6649149168662557,0.9360560093348892,0.38200089204141086,['GOT1'],0.9987231845424268,0,0,1
194,Pregnane X receptor pathway WP2876,0.6649149168662557,0.9360560093348892,0.38200089204141086,['PSMC5'],0.9987231845424268,0,0,1
195,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.6649149168662557,0.9360560093348892,0.38200089204141086,['BAX'],0.9987231845424268,0,0,1
196,Breast cancer pathway WP4262,0.6795207334704538,0.8767605633802817,0.3387518159249306,"['GADD45A', 'NOTCH4', 'BAX', 'HRAS', 'SKP1', 'DLL3']",0.9987231845424268,0,0,6
197,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.681925855027288,0.8914263488359171,0.3412686214965838,['PTGES'],0.9987231845424268,0,0,1
198,Estrogen signaling pathway WP712,0.681925855027288,0.8914263488359171,0.3412686214965838,['IKBKG'],0.9987231845424268,0,0,1
199,Nanoparticle triggered autophagic cell death WP2509,0.681925855027288,0.8914263488359171,0.3412686214965838,['MAP1LC3A'],0.9987231845424268,0,0,1
200,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6847694096260002,0.8506796941376381,0.32212953872747346,"['PIM2', 'EIF4B']",0.9987231845424268,0,0,2
201,Histone Modifications WP2369,0.6847694096260002,0.8506796941376381,0.32212953872747346,"['SET', 'H3F3B']",0.9987231845424268,0,0,2
202,One-carbon metabolism and related pathways WP3940,0.6847694096260002,0.8506796941376381,0.32212953872747346,"['GPX4', 'SOD1']",0.9987231845424268,0,0,2
203,Apoptosis WP254,0.6866481531026956,0.8505050505050505,0.31973314285809695,"['CYCS', 'BAX', 'IKBKG']",0.9987231845424268,0,0,3
204,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.6960249688416167,0.837758575543336,0.30357836098804225,"['GADD45A', 'CYCS', 'BAX']",0.9987231845424268,0,0,3
205,TLR4 Signaling and Tolerance WP3851,0.6980741662893998,0.8508539302004879,0.3058223655393458,['IKBKG'],0.9987231845424268,0,0,1
206,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6980741662893998,0.8508539302004879,0.3058223655393458,['BAX'],0.9987231845424268,0,0,1
207,Regulation of Actin Cytoskeleton WP51,0.7065993573522595,0.8499786598378147,0.29519032426196956,"['RRAS', 'TMSB4X', 'CFL1', 'BRK1', 'ARPC5', 'ACTG1']",0.9987231845424268,0,0,6
208,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.7071998373809868,0.813592035757822,0.28186245010462146,"['HOMER1', 'HRAS']",0.9987231845424268,0,0,2
209,Folate Metabolism WP176,0.7071998373809868,0.813592035757822,0.28186245010462146,"['GPX4', 'SOD1']",0.9987231845424268,0,0,2
210,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7134035460647137,0.8138095479681396,0.2748300236466878,['CALM2'],0.9987231845424268,0,0,1
211,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7134035460647137,0.8138095479681396,0.2748300236466878,['H3F3B'],0.9987231845424268,0,0,1
212,miRNAs involvement in the immune response in sepsis WP4329,0.7134035460647137,0.8138095479681396,0.2748300236466878,['IKBKG'],0.9987231845424268,0,0,1
213,Physiological and pathological hypertrophy of the heart WP1528,0.7134035460647137,0.8138095479681396,0.2748300236466878,['CALM2'],0.9987231845424268,0,0,1
214,Leptin signaling pathway WP2034,0.7228765816029115,0.801704260651629,0.26016648082728105,"['BAX', 'IKBKG', 'HRAS']",0.9987231845424268,0,0,3
215,Striated Muscle Contraction Pathway WP383,0.7279554788818937,0.779852197588487,0.2476150731292304,['ACTG1'],0.9987231845424268,0,0,1
216,Cannabinoid receptor signaling WP3869,0.7279554788818937,0.779852197588487,0.2476150731292304,['PRKAR1A'],0.9987231845424268,0,0,1
217,MTHFR deficiency WP4288,0.7279554788818937,0.779852197588487,0.2476150731292304,['CYCS'],0.9987231845424268,0,0,1
218,Interferon type I signaling pathways WP585,0.7383317291713839,0.7636372305931719,0.2316585617260726,"['RACK1', 'EIF4B']",0.9987231845424268,0,0,2
219,7-oxo-C and 7beta-HC pathways WP5064,0.7417693500881964,0.7486114352392065,0.22362291200031034,['HSD11B2'],0.9987231845424268,0,0,1
220,Toll-like Receptor Signaling related to MyD88 WP3858,0.7417693500881964,0.7486114352392065,0.22362291200031034,['IKBKG'],0.9987231845424268,0,0,1
221,White fat cell differentiation WP4149,0.7417693500881964,0.7486114352392065,0.22362291200031034,['DDIT3'],0.9987231845424268,0,0,1
222,SARS-CoV-2 mitochondrial interactions WP5038,0.7417693500881964,0.7486114352392065,0.22362291200031034,['PHB'],0.9987231845424268,0,0,1
223,Integrated breast cancer pathway WP1984,0.7442223593815269,0.8127168809961216,0.24008909765588035,"['RRAS', 'GADD45A', 'ODC1', 'BAX', 'PHB', 'FAU']",0.9987231845424268,0,0,6
224,Cardiac Hypertrophic Response WP2795,0.7480625086973198,0.7483177570093458,0.21721324999380803,"['IKBKG', 'CALM2']",0.9987231845424268,0,0,2
225,IL17 signaling pathway WP2112,0.7548825519829031,0.7197738084552554,0.20239543002527802,['IKBKG'],0.9987231845424268,0,0,1
226,Intraflagellar transport proteins binding to dynein WP4532,0.7548825519829031,0.7197738084552554,0.20239543002527802,['DYNLL1'],0.9987231845424268,0,0,1
227,Lipid Metabolism Pathway WP3965,0.7548825519829031,0.7197738084552554,0.20239543002527802,['PRKAR1A'],0.9987231845424268,0,0,1
228,Monoamine GPCRs WP58,0.7548825519829031,0.7197738084552554,0.20239543002527802,['HTR5A'],0.9987231845424268,0,0,1
229,Nanoparticle-mediated activation of receptor signaling WP2643,0.7548825519829031,0.7197738084552554,0.20239543002527802,['HRAS'],0.9987231845424268,0,0,1
230,Resistin as a regulator of inflammation WP4481,0.7548825519829031,0.7197738084552554,0.20239543002527802,['IKBKG'],0.9987231845424268,0,0,1
231,DNA IR-damage and cellular response via ATR WP4016,0.7634629900331695,0.7480233918128655,0.20188450416232556,"['FEN1', 'RPA2', 'IKBKG']",0.9987231845424268,0,0,3
232,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7665928174609856,0.7194464414090582,0.19122850111072412,"['NABP2', 'BAX']",0.9987231845424268,0,0,2
233,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.7673305845918201,0.6930723021738191,0.18355157780974113,['PPIB'],0.9987231845424268,0,0,1
234,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.7673305845918201,0.6930723021738191,0.18355157780974113,['HRAS'],0.9987231845424268,0,0,1
235,Glycerophospholipid Biosynthetic Pathway WP2533,0.7673305845918201,0.6930723021738191,0.18355157780974113,['CDIPT'],0.9987231845424268,0,0,1
236,PDGFR-beta pathway WP3972,0.7673305845918201,0.6930723021738191,0.18355157780974113,['HRAS'],0.9987231845424268,0,0,1
237,Amino Acid metabolism WP3925,0.7709743181774715,0.738134810710988,0.1919890235040726,"['GOT1', 'ODC1', 'PYCR1']",0.9987231845424268,0,0,3
238,Endochondral Ossification with Skeletal Dysplasias WP4808,0.7754057656458473,0.705827896314583,0.17954060774475694,"['SLC38A2', 'CALM2']",0.9987231845424268,0,0,2
239,Endochondral Ossification WP474,0.7754057656458473,0.705827896314583,0.17954060774475694,"['SLC38A2', 'CALM2']",0.9987231845424268,0,0,2
240,Autophagy WP4923,0.7791471513722287,0.6682780463410568,0.16677236386923946,['MAP1LC3B'],0.9987231845424268,0,0,1
241,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.7791471513722287,0.6682780463410568,0.16677236386923946,['HRAS'],0.9987231845424268,0,0,1
242,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.7791471513722287,0.6682780463410568,0.16677236386923946,['BAX'],0.9987231845424268,0,0,1
243,Circadian rhythm related genes WP3594,0.785022051252352,0.7830097736372144,0.18952240330256753,"['HOMER1', 'STAR', 'CAVIN3', 'CRH', 'RPS27A', 'UBA52', 'SKP1']",0.9987231845424268,0,0,7
244,Tumor suppressor activity of SMARCB1 WP4204,0.7903642497897846,0.6451937391864161,0.15178915919011712,['H3F3B'],0.9987231845424268,0,0,1
245,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.7903642497897846,0.6451937391864161,0.15178915919011712,['IKBKG'],0.9987231845424268,0,0,1
246,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.7903642497897846,0.6451937391864161,0.15178915919011712,['YWHAQ'],0.9987231845424268,0,0,1
247,Prion disease pathway WP3995,0.7903642497897846,0.6451937391864161,0.15178915919011712,['HSP90B1'],0.9987231845424268,0,0,1
248,3q29 copy number variation syndrome WP4906,0.792161597448043,0.6800764655904843,0.15845092785109102,"['NCBP2', 'DYNLL1']",0.9987231845424268,0,0,2
249,MET in type 1 papillary renal cell carcinoma WP4205,0.792161597448043,0.6800764655904843,0.15845092785109102,"['RPL11', 'HRAS']",0.9987231845424268,0,0,2
250,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7923429381371779,0.7099711303575394,0.16525357478716865,"['RRAS', 'BAX', 'HRAS']",0.9987231845424268,0,0,3
251,AGE/RAGE pathway WP2324,0.8001184243814349,0.667890520694259,0.14893660184161714,"['CYCS', 'SOD1']",0.9987231845424268,0,0,2
252,Cardiac Progenitor Differentiation WP2406,0.8010122578187349,0.6236483858420848,0.1383744982172013,['MESP1'],0.9987231845424268,0,0,1
253,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.8010122578187349,0.6236483858420848,0.1383744982172013,['IKBKG'],0.9987231845424268,0,0,1
254,Neovascularisation processes WP4331,0.8010122578187349,0.6236483858420848,0.1383744982172013,['NOTCH4'],0.9987231845424268,0,0,1
255,Fatty acid beta-oxidation WP143,0.8111200158333527,0.603493055294162,0.12633478406881682,['TPI1'],0.9987231845424268,0,0,1
256,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8111200158333527,0.603493055294162,0.12633478406881682,['SUPT4H1'],0.9987231845424268,0,0,1
257,miRNA regulation of prostate cancer signaling pathways WP3981,0.8111200158333527,0.603493055294162,0.12633478406881682,['IKBKG'],0.9987231845424268,0,0,1
258,Pancreatic adenocarcinoma pathway WP4263,0.818225583210934,0.6755865567533291,0.13553428763075692,"['GADD45A', 'BAX', 'IKBKG']",0.9987231845424268,0,0,3
259,Alpha 6 Beta 4 signaling pathway WP244,0.8207149042052654,0.5845974329054843,0.11550445923123732,['HRAS'],0.9987231845424268,0,0,1
260,Disruption of postsynaptic signaling by CNV WP4875,0.8207149042052654,0.5845974329054843,0.11550445923123732,['HOMER1'],0.9987231845424268,0,0,1
261,Melatonin metabolism and effects WP3298,0.8207149042052654,0.5845974329054843,0.11550445923123732,['CALM2'],0.9987231845424268,0,0,1
262,Signaling of Hepatocyte Growth Factor Receptor WP313,0.8298229171229455,0.566846999752484,0.10574131369691177,['HRAS'],0.9987231845424268,0,0,1
263,Target Of Rapamycin (TOR) Signaling WP1471,0.8298229171229455,0.566846999752484,0.10574131369691177,['IDI1'],0.9987231845424268,0,0,1
264,Pre-implantation embryo WP3527,0.8298229171229455,0.566846999752484,0.10574131369691177,['DDIT3'],0.9987231845424268,0,0,1
265,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8302615931686531,0.7074851682120147,0.13160246823709254,"['NOTCH4', 'STRAP', 'HRAS', 'MEF2D', 'DLL3']",0.9987231845424268,0,0,5
266,Bladder cancer WP2828,0.8384687327535528,0.5501407097261308,0.09692268330966643,['HRAS'],0.9987231845424268,0,0,1
267,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8384687327535528,0.5501407097261308,0.09692268330966643,['DDIT3'],0.9987231845424268,0,0,1
268,B Cell Receptor Signaling Pathway WP23,0.8413130803524366,0.6443637830207704,0.11134053097708611,"['IKBKG', 'HRAS', 'MEF2D']",0.9987231845424268,0,0,3
269,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8438961763510812,0.6916330163692415,0.11738797099005466,"['RAB3A', 'CFL1', 'RACK1', 'IKBKG', 'HRAS']",0.9987231845424268,0,0,5
270,IL-2 signaling pathway WP49,0.8466757798743022,0.5343890648441407,0.08894235008869121,['HRAS'],0.9987231845424268,0,0,1
271,Fragile X Syndrome  WP4549,0.8505426270085086,0.6611676441939027,0.10703031310144584,"['HOMER1', 'PRKAR1A', 'AP2S1', 'AP2M1']",0.9987231845424268,0,0,4
272,Vitamin D-sensitive calcium signaling in depression WP4698,0.8544663008794012,0.5195125113444833,0.08170800016506509,['GPX4'],0.9987231845424268,0,0,1
273,Oxidation by Cytochrome P450 WP43,0.8544663008794012,0.5195125113444833,0.08170800016506509,['CYP26B1'],0.9987231845424268,0,0,1
274,Acute viral myocarditis WP4298,0.8545899927506337,0.5841121495327103,0.09178356641606067,"['CYCS', 'BAX']",0.9987231845424268,0,0,2
275,Vitamin D Receptor Pathway WP2877,0.8551045324067434,0.6553268416943999,0.10257933113231299,"['CDKN2D', 'GADD45A', 'S100A6', 'HLA-DRB1']",0.9987231845424268,0,0,4
276,Endoderm differentiation WP2853,0.8551045324067434,0.6553268416943999,0.10257933113231299,"['SESN1', 'TCEAL2', 'NABP2', 'NME1']",0.9987231845424268,0,0,4
277,Vitamin A and carotenoid metabolism WP716,0.8618614120009733,0.5054400958718345,0.07513912707612277,['CYP26B1'],0.9987231845424268,0,0,1
278,Vitamin B12 metabolism WP1533,0.8618614120009733,0.5054400958718345,0.07513912707612277,['SOD1'],0.9987231845424268,0,0,1
279,Mesodermal commitment pathway WP2857,0.8638738277134504,0.6439473471695066,0.0942278838936115,"['PRKAR1A', 'SESN1', 'NABP2', 'RPL38']",0.9987231845424268,0,0,4
280,PDGF Pathway WP2526,0.86888116012455,0.49210833384511454,0.06916529377010734,['HRAS'],0.9987231845424268,0,0,1
281,Head and Neck Squamous Cell Carcinoma WP4674,0.8813768271220002,0.5416158743058377,0.06838984614850488,"['SESN1', 'HRAS']",0.9987231845424268,0,0,2
282,Chemokine signaling pathway WP3929,0.8838293022970254,0.6171444055199644,0.07621198463647143,"['GNG10', 'GNG3', 'IKBKG', 'HRAS']",0.9987231845424268,0,0,4
283,Integrated Cancer Pathway WP1971,0.8878737717220877,0.45601502689472634,0.05423190402929957,['BAX'],0.9987231845424268,0,0,1
284,Prolactin Signaling Pathway WP2037,0.8907544489823797,0.5262932736606555,0.0608850162043396,"['PPIB', 'HRAS']",0.9987231845424268,0,0,2
285,TGF-beta Receptor Signaling WP560,0.8935729864971902,0.4451297438461966,0.050089231156600855,['HRAS'],0.9987231845424268,0,0,1
286,Interleukin-11 Signaling Pathway WP2332,0.8935729864971902,0.4451297438461966,0.050089231156600855,['HRAS'],0.9987231845424268,0,0,1
287,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.8935729864971902,0.4451297438461966,0.050089231156600855,['MAP1LC3A'],0.9987231845424268,0,0,1
288,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8935729864971902,0.4451297438461966,0.050089231156600855,['BAX'],0.9987231845424268,0,0,1
289,Regulation of Microtubule Cytoskeleton WP2038,0.8935729864971902,0.4451297438461966,0.050089231156600855,['STMN1'],0.9987231845424268,0,0,1
290,"GPCRs, Class A Rhodopsin-like WP455",0.8979118907849206,0.5972459016393442,0.0643134291059043,"['MAS1', 'GPR22', 'NMUR2', 'HTR5A']",0.9987231845424268,0,0,4
291,ATM Signaling Network in Development and Disease  WP3878,0.8989828331546698,0.4347507530324822,0.0462971903358401,['IKBKG'],0.9987231845424268,0,0,1
292,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8989828331546698,0.4347507530324822,0.0462971903358401,['RAE1'],0.9987231845424268,0,0,1
293,Insulin Signaling WP481,0.899135150129813,0.6218835482610394,0.06611985408704284,"['CAP1', 'XBP1', 'HRAS', 'PFKM', 'VAMP2']",0.9987231845424268,0,0,5
294,T-cell receptor (TCR) signaling pathway WP69,0.8994398060645729,0.5118102675713737,0.05424326290531283,"['IKBKG', 'HRAS']",0.9987231845424268,0,0,2
295,Apoptosis Modulation and Signaling WP1772,0.9035370441218936,0.5048623389744885,0.051212311314147115,"['CYCS', 'BAX']",0.9987231845424268,0,0,2
296,Energy Metabolism WP1541,0.9041179873901445,0.424843534528482,0.042822278283514516,['MEF2D'],0.9987231845424268,0,0,1
297,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9074779414438373,0.49809968847352026,0.04835851636071244,"['IKBKG', 'CALM2']",0.9987231845424268,0,0,2
298,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9136192427314164,0.40632134341230786,0.036707629980337754,['HRAS'],0.9987231845424268,0,0,1
299,Rett syndrome causing genes WP4312,0.9180111266097642,0.3976513816132476,0.03401739281455909,['EIF2B2'],0.9987231845424268,0,0,1
300,Corticotropin-releasing hormone signaling pathway WP2355,0.9184148892269417,0.4788521447399952,0.040753210459940764,"['STAR', 'CRH']",0.9987231845424268,0,0,2
301,NRF2 pathway WP2884,0.9193890897512703,0.5282356835484939,0.04439602356667236,"['FTH1', 'TXN', 'SLC5A3']",0.9987231845424268,0,0,3
302,Neural Crest Differentiation WP2064,0.9250180164376892,0.46682242990654205,0.03638510390889107,"['NOTCH4', 'DLL3']",0.9987231845424268,0,0,2
303,Allograft Rejection WP2328,0.9261370399952562,0.3813730859905222,0.029263925388503486,['HLA-DRB1'],0.9987231845424268,0,0,1
304,RANKL/RANK signaling pathway WP2018,0.9298931281385093,0.37372228704784133,0.027164234429599463,['IKBKG'],0.9987231845424268,0,0,1
305,IL-1 signaling pathway WP195,0.9368425863273047,0.35930347365586573,0.0234409616297909,['IKBKG'],0.9987231845424268,0,0,1
306,Prader-Willi and Angelman Syndrome WP3998,0.9400548283770903,0.3525021465841791,0.021790652464385076,['FEZ1'],0.9987231845424268,0,0,1
307,Kit receptor signaling pathway WP304,0.9459979862670218,0.3396414553940808,0.01885514058293501,['HRAS'],0.9987231845424268,0,0,1
308,Metapathway biotransformation Phase I and II WP702,0.9466394422988192,0.4782426150847203,0.026225387913023906,"['CYP26B1', 'GPX4', 'SULT4A1']",0.9987231845424268,0,0,3
309,MAPK Signaling Pathway WP382,0.9502214717468737,0.5843138908063845,0.02983518027268732,"['HSPA8', 'RRAS', 'GADD45A', 'DDIT3', 'STMN1', 'IKBKG', 'HRAS']",0.9987231845424268,0,0,7
310,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9509394338760792,0.6002277039848197,0.03019439777184585,"['GNG10', 'GNG3', 'RAB14', 'CDC37', 'IKBKG', 'HRAS', 'EIF4B', 'HSP90B1']",0.9987231845424268,0,0,8
311,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9538274740402426,0.3220134390214461,0.015222370220275009,['HRAS'],0.9987231845424268,0,0,1
312,Oncostatin M Signaling Pathway WP2374,0.9538274740402426,0.3220134390214461,0.015222370220275009,['HRAS'],0.9987231845424268,0,0,1
313,Spinal Cord Injury WP2431,0.9570780888901541,0.401241081298362,0.017602563909219913,"['GADD45A', 'APEX1']",0.9987231845424268,0,0,2
314,TGF-beta Signaling Pathway WP366,0.9576182495090961,0.45474254742547426,0.01969311139516999,"['SUMO1', 'STRAP', 'SKP1']",0.9987231845424268,0,0,3
315,Pathways affected in adenoid cystic carcinoma WP3651,0.9625317461941283,0.301163097075319,0.011500885710567385,['HRAS'],0.9987231845424268,0,0,1
316,DNA damage response (only ATM dependent) WP710,0.9639522041382914,0.3845987089314963,0.014119990226236515,"['BAX', 'HRAS']",0.9987231845424268,0,0,2
317,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.966248308829498,0.29171528588098017,0.010015877865571043,['IDI1'],0.9987231845424268,0,0,1
318,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.966248308829498,0.29171528588098017,0.010015877865571043,['YWHAQ'],0.9987231845424268,0,0,1
319,Thermogenesis WP4321,0.9669797410942467,0.3767818370622109,0.01265148030572296,"['HRAS', 'ACTG1']",0.9987231845424268,0,0,2
320,PI3K-Akt signaling pathway WP4172,0.9679231218832611,0.5654573920823082,0.018435389314562435,"['GNG10', 'GNG3', 'CDC37', 'COL9A3', 'IKBKG', 'HRAS', 'EIF4B', 'HSP90B1']",0.9987231845424268,0,0,8
321,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9679661129621682,0.28720940669598777,0.009351021186993472,['STMN1'],0.9987231845424268,0,0,1
322,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9695965788895797,0.28284006930448,0.008732741458156128,['ACTG1'],0.9987231845424268,0,0,1
323,Hippo-Merlin Signaling Dysregulation WP4541,0.9697618073137875,0.3692745442768576,0.011338499959795656,"['PRKAR1A', 'HRAS']",0.9987231845424268,0,0,2
324,Osteoblast differentiation WP4787,0.9697618073137875,0.3692745442768576,0.011338499959795656,"['NOTCH4', 'DLL3']",0.9987231845424268,0,0,2
325,Gastrin signaling pathway WP4659,0.9723172799051869,0.3620587968423918,0.010164115752979081,"['HRAS', 'MEF2D']",0.9987231845424268,0,0,2
326,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9740071899950492,0.27049194189369724,0.007123836302922788,['SFRP2'],0.9987231845424268,0,0,1
327,Toll-like Receptor Signaling Pathway WP75,0.9765864416520226,0.2628395812447615,0.006227198162340787,['IKBKG'],0.9987231845424268,0,0,1
328,Ebola Virus Pathway on Host WP4217,0.9787934472710671,0.3420003429649318,0.007330654946678992,"['HLA-DRB1', 'ACTG1']",0.9987231845424268,0,0,2
329,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9828888083162266,0.2422676506690509,0.004181365185239647,['SFRP2'],0.9987231845424268,0,0,1
330,Glioblastoma signaling pathways WP2261,0.9853724906523241,0.23313885647607935,0.0034354283898922113,['HRAS'],0.9987231845424268,0,0,1
331,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9861175936632928,0.23024619329559043,0.003218765372912035,['HRAS'],0.9987231845424268,0,0,1
332,Nuclear Receptors Meta-Pathway WP2882,0.9862786684205656,0.4682802698544206,0.006469919019701657,"['PSMC5', 'FTH1', 'CDC37', 'BAX', 'TXN', 'SLC5A3']",0.9987231845424268,0,0,6
333,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9870637231842456,0.3104361370716511,0.004042089333035802,"['CAP1', 'HRAS']",0.9987231845424268,0,0,2
334,Pathways Regulating Hippo Signaling WP4540,0.988737602720902,0.21935616720433798,0.002484493386826807,['PRKAR1A'],0.9987231845424268,0,0,1
335,ErbB signaling pathway WP673,0.9893114303519178,0.21679194594447912,0.002329668524369082,['HRAS'],0.9987231845424268,0,0,1
336,Integrin-mediated Cell Adhesion WP185,0.9921903760266909,0.20257724113439196,0.0015882620475408695,['HRAS'],0.9987231845424268,0,0,1
337,Wnt signaling WP428,0.994585194999591,0.18817109248847871,0.0010216783702051819,['SFRP2'],0.9987231845424268,0,0,1
338,ESC Pluripotency Pathways WP3931,0.9948612378799289,0.1862777129521587,0.0009597048198639481,['HRAS'],0.9987231845424268,0,0,1
339,Genes related to primary cilium development (based on CRISPR) WP4536,0.995123216410868,0.18442182607992422,0.0009015855449385848,['DYNLL1'],0.9987231845424268,0,0,1
340,Regulation of toll-like receptor signaling pathway WP1449,0.9953718462417718,0.182602329146361,0.0008470733643087673,['IKBKG'],0.9987231845424268,0,0,1
341,Male infertility WP4673,0.9956078068275077,0.1808181622503427,0.0007959375357814831,['CYP26B1'],0.9987231845424268,0,0,1
342,Focal Adhesion WP306,0.9958705174132454,0.30962962962962964,0.0012812574535736065,"['HRAS', 'MYL12B', 'ACTG1']",0.9987231845424268,0,0,3
343,Ectoderm Differentiation WP2858,0.998681940334785,0.1475986738530496,0.00019467218162215165,['LY6E'],0.9987231845424268,0,0,1
344,Ciliopathies WP4803,0.9987231845424268,0.21844420010995053,0.0002790911432005502,"['NEK2', 'CCNQ']",0.9987231845424268,0,0,2
